About Us
at a pace and efficiency never achieved before.
Our Story
Armed with an ever-growing understanding of cancer biology, Corellia AI was launched out of Champions Oncology, Inc. in 2023, leveraging Champions’ deep cancer dataset, rich suite of research platforms, and state-of-the-art experimental capabilities established over the past 15 years.
Corellia AI has built a unique research ecosystem and partnered with world-leading biopharma and technology companies to execute our vision of building transformative first-in-class therapeutics.
History of Corellia AI
Corellia AI launched out of Champions Oncology, a technology-driven research organization formed in 2008, leveraging the unique platform consisting of a world-leading bank of PDX models, a multi-omic dataset, and extensive experimental capabilities.
Meet The Team
Corellia AI empowers a global team of passionate scientists, drug developers, and innovators. We combine our collective human intelligence with powerful artificial intelligence to revolutionize the discovery of novel oncology therapeutics
Ronnie Morris, MD
Executive Chairman
Michael Ritchie, PhD, MBA
Chief Executive Officer
Kakajan Komurov, PhD
Chief Scientific/Technology Officer
Josh Levine, JD
Chief Business Officer
Your Career at Corellia AI
At Corellia AI, you can build your career in a data-driven, fast-paced environment created for successful drug discovery. Join a team of passionate scientists with a goal to create transformative, first-in-class therapeutics. Join Corellia AI.
Open Positions
There are no open positions at this time.